VivoSim Labs, Inc. Number of Operating Segments
VivoSim Labs, Inc. (VIVS) reported Number of Operating Segments of 1 Segment for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:NumberOfOperatingSegments · last filed 2026-08-12
- VivoSim Labs, Inc. number of operating segments for the quarter ending 2026-06-30 was 1.00 Segment.
- VivoSim Labs, Inc. number of operating segments for fiscal 2026 was 1.00 Segment, a 0.00% change from fiscal 2025.
- VivoSim Labs, Inc. number of operating segments for fiscal 2025 was 1.00 Segment, a 50.00% decline from fiscal 2024.
- VivoSim Labs, Inc. number of operating segments for fiscal 2024 was 2.00 Segment.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 12 month |
|---|---|---|
| 2026-06-30 | 1.00 Segment 10-Q · filed 2026-08-12 | |
| 2026-03-31 | 1.00 Segment 10-K · filed 2026-07-14 | |
| 2025-03-31 | 1.00 Segment 10-K · filed 2025-06-05 | |
| 2024-03-31 | 2.00 Segment 10-K · filed 2025-06-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |